Ambulance-delivered treatment for suspected stroke
Official title: An Investigator Initiated and Conducted, Prospective, Multicentre, Randomised Outcome-blinded Study of Pre-hospital Initiated Levetiracetam and Headposition in Patients With Presumed Acute Stroke
Run by Shanghai East Hospital · NCT06773364 · Data updated 2026-11-12
This study tests if giving a medication called levetiracetam and adjusting head positions to stroke patients in the ambulance can help them recover better than standard care.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2423 (estimated) |
| Sponsor | Shanghai East Hospital Academic / other |
| Locations | 2 sites (Suzhou, Anhui and 1 other locations) |
| Status | Recruiting |
| Started | April 30, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | May 22, 2025 |
| Trial ID | NCT06773364 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who show symptoms of an acute stroke within 2 hours of last being well.
✕Probably not a fit
Patients who are in a coma, have severe co-morbid diseases, or have contraindications to levetiracetam will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the effects of administering levetiracetam and different head positions to patients with suspected acute stroke while they are still in the ambulance. It is a multicenter, randomized controlled trial involving 2323 patients across approximately 50 hospitals in China. Participants will receive either levetiracetam or standard care, and their functional outcomes will be assessed 90 days after treatment. The study aims to determine if these interventions can improve recovery outcomes for stroke patients.
Why it matters
Potential benefit: If successful, this approach could lead to improved functional outcomes for patients experiencing acute strokes.
How similar studies have gone: While similar approaches have been explored, this specific intervention combining ambulance-delivered levetiracetam and head positioning is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (age ≥18 years); * Acute condition that is presumed due to acute stroke, defined on the FAST (Face, Arm, Speech, Time) screen (score ≥2 with an arm deficit); * Time ≤2 hours from last seen well; * Able to provide brief consent (if a waver of consent not approved by ethics committee). Exclusion Criteria: * coma (no response to painful stimulation); * severe co-morbid disease (e.g. cancer, chronic airflow disease, severe dementia, severe heart failure, pre-existing disability \[needing help with everyday activities\]); * history of epilepsy or seizure at onset; * recent head injury; * hypoglycaemia (glucose \<2.8mmol/L); * clear indications or contraindications (allergies) for levetiracetam; * lactating women; * clear indications for a particular head position or situations where either head position cannot be maintained (such as severe vomiting and inability to lie down, severe obesity with fatigue and difficulty sitting up, etc.).
Where it's running
-
Si County People's Hospital
Suzhou, Anhui, China Recruiting -
Shanghai East Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: Gang Li, PhD, MD — Tongji University, School of Medicine, Shanghai East Hospital
- Study coordinator: Gang Li, PhD, MD
- Email: ligang@tongji.edu.cn
- Phone: 86 13621691786
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulse electric field ablation system for adults with type 2 diabetes and suboptimal drug control
This study tests a pulse electric field ablation approach in adults with type 2 diabetes whose blood sugar remains above target despite medications.
-
MRI-guided prostate biopsy using targeted sampling only for high-risk men
This study tests whether a targeted MRI-guided prostate biopsy alone can safely replace the standard combined biopsy in men with very high PSA and suspicious MRI.
-
Testing molecular markers to identify high-risk colorectal polyps in people with MASH
This project will test whether specific gene-expression markers in polyp tissue and blood can identify high-risk colorectal polyps in adults with metabolic dysfunction-associated steatohepatitis (MASH) who are having colonoscopic polyp removal.
-
Blood pressure management during early clot‑busting treatment for acute ischemic stroke
This trial will test whether an adjusted blood pressure approach is safer than usual care for people with acute ischemic stroke who are receiving IV thrombolysis and have high blood pressure.
-
68Ga-FAPI PET combined with cardiac MRI for heart disease
This project will test whether 68Ga-FAPI PET together with cardiac MRI can find early scarring (fibrosis) of the heart muscle in adults with cardiovascular disease.
-
Rapid blood test using GFAP to tell hemorrhagic vs ischemic stroke
This project will test whether a quick blood test for GFAP can tell if adults with suspected stroke have bleeding in the brain when they arrive within three hours of symptom onset.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.